您的位置: 首页 > 农业专利 > 详情页

Novel substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
专利权人:
Merck Sharp & Dohme Corp.
发明人:
Guo, Liangqin,Han, Yongxin,Liu, Kun,He, Shuwen,Kozlowski, Joseph,Nargund, Ravi,Yu, Wensheng,Zhang, Hongjun,Pu, Qinglin,Li, Derun,Achab, Abdelghani,Li, Guoqing
申请号:
AU2018243640
公开号:
AU2018243640A1
申请日:
2018.03.23
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof. Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充